1-3
2026
影响因子区间
—
平台估算
45%
2025
中国作者发文占比
2690 EUR;3390 USD;2290 GBP
收费
期刊简介:Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy.The Journal includes:Clinical research on new and established drugs;Preclinical research of direct relevance to clinical drug development;Short communications and case study reports that meet the above criteria will also be considered;Reviews may also be considered.
【译文】这是一本国际性的、同行评审的、开放获取的、仅在线的期刊,提供了关于药物研发所有阶段的信息,这些信息将有助于临床实践。因此,医疗决策者可以了解药物在治疗中的发展位置。该期刊包括:新药和现有药物的临床研究;与临床药物开发直接相关的临床前研究;符合上述标准的简报和案例研究报告也将被考虑;评论也可能被考虑。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |